Whitepaper

Challenges and opportunities for the adoption of 3D printing technologies in the Pharmaceutical Industry: An overview of additive manufacturing techniques, the case for Fixed-Dose Combinations

Challenges and opportunities for the adoption of 3D printing technologies in the Pharmaceutical Industry: An overview of additive manufacturing techniques, the case for Fixed-Dose Combinations

Fixed-dose combinations are the preferred approach to simplify the management of chronic diseases such as HIV, asthma, diabetes, lipid regulation, and hypertension by reducing the number of dosage intake and improving efficacy as well as offering a more cost-effective therapeutic option to monotherapy. However, there are various challenges in the fabrication of multi-layered tablets that need to be considered to achieve optimal manufacturing at an industrial scale. This whitepaper from Procaps provides an overview of recent academic works regarding the implementation of how Additive Manufacturing (3D Printing) technologies have emerged to develop pharmaceutical products, particularly the design and manufacturing of dose combination products for chronic patients.